Unlocking the Potential of Cancer Immunotherapy with 3D Immune Cell Killing Assays
CAR T-cell therapies have shown impressive results in treating hematological malignancies. However, developing specialized therapies for the treatment of solid tumors still remains a challenge.
3D cell culture models are essential in researching how therapies can infiltrate and remain effective in solid tumor microenvironments. By optimizing 3D cell killing assays using the latest analysis/analytical technologies, researchers can guide and accelerate the engineering of novel therapeutics.
This literature review explores a range of successful assay setups that leverage different analytical technologies.
Download this literature review to discover:
- Different assay setups for 3D killing assays
- High-content analysis, image cytometry and in vivo imaging for 3D killing assays
- Benefits and challenges of the different technologies